Search Results - "Stonebraker, Jeffrey S."

Refine Results
  1. 1

    Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries by Iorio, Alfonso, Stonebraker, Jeffrey S, Chambost, Hervé, Makris, Michael, Coffin, Donna, Herr, Christine, Germini, Federico

    Published in Annals of internal medicine (15-10-2019)
    “…The large observed variability in hemophilia prevalence prevents robust estimation of burden of disease. To estimate the prevalence and prevalence at birth of…”
    Get full text
    Journal Article
  2. 2

    Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time by Stonebraker, Jeffrey S., O'Mahony, Brian, Noone, Declan, Iorio, Alfonso

    “…Introduction The World Federation of Hemophilia started measuring factor utilization at the country level as IU/capita (International Units of factor…”
    Get full text
    Journal Article
  3. 3

    The World Federation of Hemophilia Annual Global Survey 1999‐2018 by Stonebraker, Jeffrey S., Bolton‐Maggs, Paula H. B., Brooker, Mark, Evatt, Bruce, Iorio, Alfonso, Makris, Michael, O'Mahony, Brian, Skinner, Mark W., Coffin, Donna, Pierce, Glenn F., Tootoonchian, Ellia

    “…Introduction The World Federation of Hemophilia (WFH) strives to achieve care for all patients with inherited bleeding disorders through research, advocacy,…”
    Get full text
    Journal Article
  4. 4

    Modelling future usage and cost of factor and emicizumab to treat haemophilia A for the US Western States Region IX haemophilia treatment centres by Stonebraker, Jeffrey S., Ducore, Jonathan M.

    “…Introduction Increased usage of emicizumab in the United States will affect standard half‐life (SHL) and extended half‐life (EHL) products usage and cost. Aim…”
    Get full text
    Journal Article
  5. 5

    Non‐severe haemophilia: Is it benign? – Insights from the PROBE study by Chai‐Adisaksopha, Chatree, Noone, Declan, Curtis, Randall, Frick, Neil, Nichol, Michael B., Germini, Federico, O'Mahony, Brian, Page, David, Stonebraker, Jeffrey S., Skinner, Mark W., Iorio, Alfonso

    “…Introduction There are limited data on the impact of haemophilia on health status and health‐related quality of life (HRQL) in people with non‐severe (mild and…”
    Get full text
    Journal Article
  6. 6

    Reported prevalence of von Willebrand disease worldwide in relation to income classification by Stonebraker, Jeffrey S., Iorio, Alfonso, Lavin, Michelle, Rezende, Suely M., Srivastava, Alok, Pierce, Glenn F., Coffin, Donna, Tootoonchian, Ellia, Makris, Michael

    “…Introduction The diagnosis of von Willebrand disease (VWD) is complex and challenging, especially when diagnostic resources are limited. This results in a lack…”
    Get full text
    Journal Article
  7. 7

    Product-Generation Transition Decision Making for Bayer's Hemophilia Drugs: Global Capacity Expansion Under Uncertainty with Supply-Demand Imbalances by Stonebraker, Jeffrey S.

    Published in Operations research (01-09-2013)
    “…We present an application of decision analysis to global production capacity expansion under uncertainty for Bayer Group's proposed new biotechnology drug to…”
    Get full text
    Journal Article
  8. 8

    Modeling Primary Immunodeficiency Disease Epidemiology and Its Treatment to Estimate Latent Therapeutic Demand for Immunoglobulin by Stonebraker, Jeffrey S., Farrugia, Albert, Gathmann, Benjamin, Orange, Jordan S.

    Published in Journal of clinical immunology (01-02-2014)
    “…Purpose Estimating the underlying demand for immunoglobulin (Ig) is important to ensure that adequate provision is made for patients with primary immune…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Impact factor as a metric to assess journals where OM research is published by Stonebraker, Jeffrey S., Gil, Esther, Kirkwood, Craig W., Handfield, Robert B.

    Published in Journal of operations management (01-01-2012)
    “…► We conducted an exhaustive comparison of OM journal rankings based on impact factors versus other ranking methods (113 characters) ► Impact factors are…”
    Get full text
    Journal Article
  11. 11

    Modeling Potential Demand for Supply-Constrained Drugs: A New Hemophilia Drug at Bayer Biological Products by Stonebraker, Jeffrey S., Keefer, Donald L.

    Published in Operations research (01-01-2009)
    “…This paper describes the evolution and application of a novel approach for forecasting drug demand in markets where supply limitations have significantly…”
    Get full text
    Journal Article
  12. 12

    OR Practice--Modeling Potential Demand for Supply-Constrained Drugs: A New Hemophilia Drug at Bayer Biological Products by Stonebraker, Jeffrey S, Keefer, Donald L

    Published in Operations research (01-02-2009)
    “…This paper describes the evolution and application of a novel approach for forecasting drug demand in markets where supply limitations have significantly…”
    Get full text
    Journal Article
  13. 13

    Case—Bayer New Drug Development Decision Making by Stonebraker, Jeffrey S.

    Published in Transactions on education (01-05-2023)
    “…History: This paper has been accepted for the INFORMS Transactions on Education Special Section on Cases Based on Real-World Projects from the INFORMS Journal…”
    Get full text
    Journal Article
  14. 14

    Case Article—Bayer New Drug Development Decision Making by Stonebraker, Jeffrey S.

    Published in Transactions on education (01-05-2023)
    “…The interactive case study requires student teams to engage with the instructor using a structured decision analysis process in deciding whether to develop a…”
    Get full text
    Journal Article
  15. 15

    Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males by Iorio, Alfonso, Stonebraker, Jeffrey, Chambost, Hervé, Makris, Michael, Coffin, Donna, Herr, Christine, Germini, Federico

    Published in Annals of internal medicine (15-10-2019)
    “…Background: The large observed variability in hemophilia prevalence prevents robust estimation of burden of disease.Objective: To estimate the prevalence and…”
    Get full text
    Journal Article
  16. 16

    NC State's Supply Chain Resource Cooperative Educates in the Real World by Handfield, Robert B., Edwards, Steven A., Stonebraker, Jeffrey S.

    Published in Interfaces (Providence) (01-11-2011)
    “…North Carolina State University's Supply Chain Resource Cooperative (SCRC) is a unique university-industry initiative that provides MBA and undergraduate…”
    Get full text
    Journal Article
  17. 17

    Practice Summaries: American Airlines Uses Should-Cost Modeling to Assess the Uncertainty of Bids for Its Full-Truckload Shipment Routes by Bailey, Michael J., Snapp, John, Yetur, Subramani, Stonebraker, Jeffrey S., Edwards, Steven A., Davis, Aaron, Cox, Robert

    Published in Interfaces (Providence) (01-03-2011)
    “…We used decision analysis to develop a probabilistic model to help American Airlines assess the uncertainty of bid quotes for its full-truckload (FTL)…”
    Get full text
    Journal Article
  18. 18

    How Bayer Makes Decisions to Develop New Drugs by Stonebraker, Jeffrey S

    Published in Interfaces (Providence) (01-11-2002)
    “…Drug development is time consuming, resource intensive, risky, and heavily regulated. To ensure that it makes the best drug-development decisions, Bayer…”
    Get full text
    Journal Article
  19. 19

    Formulating and solving sequential decision analysis models with continuous variables by Stonebraker, J.S., Kirkwood, C.W.

    “…This paper presents a new decision analysis approach for modeling decision problems with continuous decision and/or random variables, and applies the approach…”
    Get full text
    Journal Article
  20. 20

    New York Power Authority Uses Decision Analysis to Schedule Refueling of Its Indian Point 3 Nuclear Power Plant by Dunning, Dennis J, Lockfort, Steve, Ross, Quentin E, Beccue, Phillip C, Stonebraker, Jeffrey S

    Published in Interfaces (Providence) (01-09-2001)
    “…The New York Power Authority (NYPA) wanted to develop a 10-year schedule for refueling its Indian Point 3 Nuclear Power Plant (IP3) that balanced fish…”
    Get full text
    Journal Article